Oh, the Places We’ll Go: Patient-Reported Outcomes and Electronic Health Records

被引:0
|
作者
Sarah G. Gensheimer
Albert W. Wu
Claire F. Snyder
机构
[1] Johns Hopkins School of Medicine,Department of Health Policy and Management
[2] Johns Hopkins Bloomberg School of Public Health,undefined
[3] Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The growing measurement of patient-reported outcomes (PROs) and adoption of electronic health records (EHRs) presents an unprecedented opportunity to improve health care for patients and populations. The integration of PROs into EHRs can promote patient-centered care and advance quality improvement initiatives, research, and population health. Despite these potential benefits, there are few best practices to help organizations achieve integration. To integrate PROs into EHRs, organizations should evaluate the advantages and disadvantages of various approaches within three themes: Planning, Selection, and Engagement. Planning considerations for integration include what strategy will be used, how the integrated system will be governed, ethical and legal issues, and how data from multiple EHRs can be pooled across organizations. Selection considerations involve identifying which patient population to target for PRO data collection on the basis of the intended use of the data in the health care system, and then choosing specific outcomes and their measures. Engagement considerations include how, where, and with what frequency patients will respond to PRO measures, how to display PRO data in EHRs, how clinical teams will act upon PRO data, and how to train, support and incent clinical teams and patients to incorporate PRO data into care. There is no most effective model that will work in all contexts. Organizations wishing to integrate PROs and EHRs should assemble the multidisciplinary expertise needed to evaluate the advantages and disadvantages of the various approaches for their particular context. We specifically recommend that organizations think carefully about stakeholder participation; design their system with data sharing in mind; develop a framework to aid in PRO selection; create guidelines to support PRO interpretation and action for patients and clinicians; and ensure patients have access to their own PRO data.
引用
收藏
页码:591 / 598
页数:7
相关论文
共 50 条
  • [1] Oh, the Places We'll Go: Patient-Reported Outcomes and Electronic Health Records
    Gensheimer, Sarah G.
    Wu, Albert W.
    Snyder, Claire F.
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2018, 11 (06): : 591 - 598
  • [2] Oh, the places we'll go
    Mocco, J.
    [J]. JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2022, 14 (04)
  • [3] OH THE PLACES WE'LL GO
    Saqqa, Osaid
    Atari, Mohammad
    Giusti-Torres, Sixto
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S345 - S345
  • [4] Oh, the places we’ll go …
    Courtney Hulce
    [J]. TechTrends, 1999, 43 (5) : 3 - 3
  • [5] Integrating patient-reported outcomes in electronic health records: design considerations
    Halyard, M.
    Hess, R.
    Jensen, R.
    Lavallee, D.
    Weinfurt, K.
    [J]. QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 3 - 3
  • [6] Oh, the places we've been. Oh, the places we'll go.
    Mitchell, E
    [J]. CHEMICAL INNOVATION, 2001, 31 (12): : 64 - 65
  • [7] Towards an effective framework for integrating patient-reported outcomes in electronic health records
    Wang, Panzhang
    Li, Tao
    Yu, Lei
    Zhou, Liang
    Yan, Tao
    [J]. DIGITAL HEALTH, 2022, 8
  • [8] The Places We'll Go
    Ulen, Thomas S.
    [J]. ASIAN JOURNAL OF LAW AND ECONOMICS, 2024, 15 (02) : 281 - 302
  • [9] Overcoming barriers to integrating patient-reported outcomes in clinical practice and electronic health records
    Basch, E.
    Snyder, C.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (10) : 2332 - 2333
  • [10] The comorbid burden of gout on health outcomes: Results from linking electronic health records to patient-reported outcomes
    Huynh, Stephanie
    Jaffe, Dena
    Strader, Carey
    Haskell, Tom
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 119 - 120